These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 10446221)
1. Disruption of ligand binding to the insulin-like growth factor II/mannose 6-phosphate receptor by cancer-associated missense mutations. Byrd JC; Devi GR; de Souza AT; Jirtle RL; MacDonald RG J Biol Chem; 1999 Aug; 274(34):24408-16. PubMed ID: 10446221 [TBL] [Abstract][Full Text] [Related]
2. Altered ligand binding by insulin-like growth factor II/mannose 6-phosphate receptors bearing missense mutations in human cancers. Devi GR; De Souza AT; Byrd JC; Jirtle RL; MacDonald RG Cancer Res; 1999 Sep; 59(17):4314-9. PubMed ID: 10485478 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms for high affinity mannose 6-phosphate ligand binding to the insulin-like growth factor II/mannose 6-phosphate receptor. Byrd JC; MacDonald RG J Biol Chem; 2000 Jun; 275(25):18638-46. PubMed ID: 10764735 [TBL] [Abstract][Full Text] [Related]
4. Mannose 6-phosphate/insulin-like growth factor II receptor: distinct binding sites for mannose 6-phosphate and insulin-like growth factor II. Braulke T; Causin C; Waheed A; Junghans U; Hasilik A; Maly P; Humbel RE; von Figura K Biochem Biophys Res Commun; 1988 Feb; 150(3):1287-93. PubMed ID: 2963636 [TBL] [Abstract][Full Text] [Related]
5. An insulin-like growth factor II (IGF-II) affinity-enhancing domain localized within extracytoplasmic repeat 13 of the IGF-II/mannose 6-phosphate receptor. Devi GR; Byrd JC; Slentz DH; MacDonald RG Mol Endocrinol; 1998 Nov; 12(11):1661-72. PubMed ID: 9817593 [TBL] [Abstract][Full Text] [Related]
6. High-affinity ligand binding by wild-type/mutant heteromeric complexes of the mannose 6-phosphate/insulin-like growth factor II receptor. Hartman MA; Kreiling JL; Byrd JC; MacDonald RG FEBS J; 2009 Apr; 276(7):1915-29. PubMed ID: 19236480 [TBL] [Abstract][Full Text] [Related]
7. Structure and function of the human Gly1619Arg polymorphism of M6P/IGF2R domain 11 implicated in IGF2 dependent growth. Rezgui D; Williams C; Savage SA; Prince SN; Zaccheo OJ; Jones EY; Crump MP; Hassan AB J Mol Endocrinol; 2009 Apr; 42(4):341-56. PubMed ID: 19208780 [TBL] [Abstract][Full Text] [Related]
8. A novel binding site for the human insulin-like growth factor-II (IGF-II)/mannose 6-phosphate receptor on IGF-II. Delaine C; Alvino CL; McNeil KA; Mulhern TD; Gauguin L; De Meyts P; Jones EY; Brown J; Wallace JC; Forbes BE J Biol Chem; 2007 Jun; 282(26):18886-94. PubMed ID: 17475626 [TBL] [Abstract][Full Text] [Related]
9. Opposing roles for the insulin-like growth factor (IGF)-II and mannose 6-phosphate (Man-6-P) binding activities of the IGF-II/Man-6-P receptor in the growth of prostate cancer cells. Schaffer BS; Lin MF; Byrd JC; Park JH; MacDonald RG Endocrinology; 2003 Mar; 144(3):955-66. PubMed ID: 12586773 [TBL] [Abstract][Full Text] [Related]
10. Mannose 6-phosphate/insulin like growth factor II receptor: the two types of ligands bind simultaneously to one receptor at different sites. Waheed A; Braulke T; Junghans U; von Figura K Biochem Biophys Res Commun; 1988 May; 152(3):1248-54. PubMed ID: 2454100 [TBL] [Abstract][Full Text] [Related]
11. Kinetics of insulin-like growth factor II (IGF-II) interaction with domain 11 of the human IGF-II/mannose 6-phosphate receptor: function of CD and AB loop solvent-exposed residues. Zaccheo OJ; Prince SN; Miller DM; Williams C; Kemp CF; Brown J; Jones EY; Catto LE; Crump MP; Hassan AB J Mol Biol; 2006 Jun; 359(2):403-21. PubMed ID: 16631789 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of insulin-like growth factor II (IGF-II)-dependent cell growth by multidentate pentamannosyl 6-phosphate-based ligands targeting the mannose 6-phosphate/IGF-II receptor. Zavorka ME; Connelly CM; Grosely R; MacDonald RG Oncotarget; 2016 Sep; 7(38):62386-62410. PubMed ID: 27694692 [TBL] [Abstract][Full Text] [Related]
13. Binding of urokinase-type plasminogen activator receptor (uPAR) to the mannose 6-phosphate/insulin-like growth factor II receptor: contrasting interactions of full-length and soluble forms of uPAR. Kreiling JL; Byrd JC; Deisz RJ; Mizukami IF; Todd RF; MacDonald RG J Biol Chem; 2003 Jun; 278(23):20628-37. PubMed ID: 12665524 [TBL] [Abstract][Full Text] [Related]
14. Mannose 6-phosphate/insulin-like growth factor II receptor fails to interact with G-proteins. Analysis of mutant cytoplasmic receptor domains. Körner C; Nürnberg B; Uhde M; Braulke T J Biol Chem; 1995 Jan; 270(1):287-95. PubMed ID: 7814388 [TBL] [Abstract][Full Text] [Related]
15. The bovine mannose 6-phosphate/insulin-like growth factor II receptor. The role of arginine residues in mannose 6-phosphate binding. Dahms NM; Rose PA; Molkentin JD; Zhang Y; Brzycki MA J Biol Chem; 1993 Mar; 268(8):5457-63. PubMed ID: 8449908 [TBL] [Abstract][Full Text] [Related]
16. Interactions of IGF-II with the IGF2R/cation-independent mannose-6-phosphate receptor mechanism and biological outcomes. Brown J; Jones EY; Forbes BE Vitam Horm; 2009; 80():699-719. PubMed ID: 19251056 [TBL] [Abstract][Full Text] [Related]
17. The bovine mannose 6-phosphate/insulin-like growth factor II receptor. Localization of the insulin-like growth factor II binding site to domains 5-11. Dahms NM; Wick DA; Brzycki-Wessell MA J Biol Chem; 1994 Feb; 269(5):3802-9. PubMed ID: 8106425 [TBL] [Abstract][Full Text] [Related]
18. Role of phosphorylation and dephosphorylation in the functions of mannose-6-phosphate/insulin like growth factor II receptor. Balasubramanian AS Indian J Biochem Biophys; 1997; 34(1-2):178-80. PubMed ID: 9343947 [No Abstract] [Full Text] [Related]
19. The two mannose 6-phosphate binding sites of the insulin-like growth factor-II/mannose 6-phosphate receptor display different ligand binding properties. Marron-Terada PG; Brzycki-Wessell MA; Dahms NM J Biol Chem; 1998 Aug; 273(35):22358-66. PubMed ID: 9712856 [TBL] [Abstract][Full Text] [Related]